Is local resection sufficient for parathyroid carcinoma?

Detalhes bibliográficos
Autor(a) principal: Basceken, Salim Ilksen
Data de Publicação: 2015
Outros Autores: Genc, Volkan, Ersoz, Siyar, Sevim, Yusuf, Celik, Suleyman Utku, Bayram, Ilknur Kepenekci
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/100987
Resumo: OBJECTIVES: Parathyroid carcinoma is a rare malignant disease of the parathyroid glands that appears in less than 1% of patients with primary hyperparathyroidism. In the literature, the generally recommended treatment is en bloc tumor excision with ipsilateral thyroid lobectomy. Based on our 12 years of experience, we discuss the necessity of performing thyroid lobectomy on parathyroid carcinoma patients. RESULTS: Eleven parathyroid carcinoma cases were included in the study. All operations were performed at the Department of Endocrine Surgery at Ankara University Medical School. Seven of the patients were male (63.6%), and the mean patient age was 48.9 ± 14.0 years. Hyperparathyroidism was the most common indication for surgery (n ϝ 10, 90.9%). Local disease was detected in 5 patients (45.5%), invasive disease was detected in 5 patients (45.5%) and metastatic disease was detected in 1 patient (9.1%). The mean follow-up period was 99.6 ± 42.1 months, and the patients' average disease-free survival was 96.0 ± 49.0 months. During the follow-up period, only 1 patient died of metastatic parathyroid carcinoma. CONCLUSION: Parathyroid carcinoma has a slow-growing natural progression, and regional lymph node metastases are uncommon. Although our study comprised few patients, it nevertheless showed that in selected cases, parathyroid carcinoma could be solely treated with parathyroidectomy.
id USP-19_c757b951574e2a6141e9d1ae9f13a7a2
oai_identifier_str oai:revistas.usp.br:article/100987
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Is local resection sufficient for parathyroid carcinoma?OBJECTIVES: Parathyroid carcinoma is a rare malignant disease of the parathyroid glands that appears in less than 1% of patients with primary hyperparathyroidism. In the literature, the generally recommended treatment is en bloc tumor excision with ipsilateral thyroid lobectomy. Based on our 12 years of experience, we discuss the necessity of performing thyroid lobectomy on parathyroid carcinoma patients. RESULTS: Eleven parathyroid carcinoma cases were included in the study. All operations were performed at the Department of Endocrine Surgery at Ankara University Medical School. Seven of the patients were male (63.6%), and the mean patient age was 48.9 ± 14.0 years. Hyperparathyroidism was the most common indication for surgery (n ϝ 10, 90.9%). Local disease was detected in 5 patients (45.5%), invasive disease was detected in 5 patients (45.5%) and metastatic disease was detected in 1 patient (9.1%). The mean follow-up period was 99.6 ± 42.1 months, and the patients' average disease-free survival was 96.0 ± 49.0 months. During the follow-up period, only 1 patient died of metastatic parathyroid carcinoma. CONCLUSION: Parathyroid carcinoma has a slow-growing natural progression, and regional lymph node metastases are uncommon. Although our study comprised few patients, it nevertheless showed that in selected cases, parathyroid carcinoma could be solely treated with parathyroidectomy.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2015-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/10098710.6061/clinics/2015(04)05Clinics; Vol. 70 No. 4 (2015); 247-249Clinics; v. 70 n. 4 (2015); 247-249Clinics; Vol. 70 Núm. 4 (2015); 247-2491980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/100987/99651Copyright (c) 2015 Clinicsinfo:eu-repo/semantics/openAccessBasceken, Salim IlksenGenc, VolkanErsoz, SiyarSevim, YusufCelik, Suleyman UtkuBayram, Ilknur Kepenekci2015-07-28T13:19:56Zoai:revistas.usp.br:article/100987Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2015-07-28T13:19:56Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Is local resection sufficient for parathyroid carcinoma?
title Is local resection sufficient for parathyroid carcinoma?
spellingShingle Is local resection sufficient for parathyroid carcinoma?
Basceken, Salim Ilksen
title_short Is local resection sufficient for parathyroid carcinoma?
title_full Is local resection sufficient for parathyroid carcinoma?
title_fullStr Is local resection sufficient for parathyroid carcinoma?
title_full_unstemmed Is local resection sufficient for parathyroid carcinoma?
title_sort Is local resection sufficient for parathyroid carcinoma?
author Basceken, Salim Ilksen
author_facet Basceken, Salim Ilksen
Genc, Volkan
Ersoz, Siyar
Sevim, Yusuf
Celik, Suleyman Utku
Bayram, Ilknur Kepenekci
author_role author
author2 Genc, Volkan
Ersoz, Siyar
Sevim, Yusuf
Celik, Suleyman Utku
Bayram, Ilknur Kepenekci
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Basceken, Salim Ilksen
Genc, Volkan
Ersoz, Siyar
Sevim, Yusuf
Celik, Suleyman Utku
Bayram, Ilknur Kepenekci
description OBJECTIVES: Parathyroid carcinoma is a rare malignant disease of the parathyroid glands that appears in less than 1% of patients with primary hyperparathyroidism. In the literature, the generally recommended treatment is en bloc tumor excision with ipsilateral thyroid lobectomy. Based on our 12 years of experience, we discuss the necessity of performing thyroid lobectomy on parathyroid carcinoma patients. RESULTS: Eleven parathyroid carcinoma cases were included in the study. All operations were performed at the Department of Endocrine Surgery at Ankara University Medical School. Seven of the patients were male (63.6%), and the mean patient age was 48.9 ± 14.0 years. Hyperparathyroidism was the most common indication for surgery (n ϝ 10, 90.9%). Local disease was detected in 5 patients (45.5%), invasive disease was detected in 5 patients (45.5%) and metastatic disease was detected in 1 patient (9.1%). The mean follow-up period was 99.6 ± 42.1 months, and the patients' average disease-free survival was 96.0 ± 49.0 months. During the follow-up period, only 1 patient died of metastatic parathyroid carcinoma. CONCLUSION: Parathyroid carcinoma has a slow-growing natural progression, and regional lymph node metastases are uncommon. Although our study comprised few patients, it nevertheless showed that in selected cases, parathyroid carcinoma could be solely treated with parathyroidectomy.
publishDate 2015
dc.date.none.fl_str_mv 2015-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/100987
10.6061/clinics/2015(04)05
url https://www.revistas.usp.br/clinics/article/view/100987
identifier_str_mv 10.6061/clinics/2015(04)05
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/100987/99651
dc.rights.driver.fl_str_mv Copyright (c) 2015 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2015 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 70 No. 4 (2015); 247-249
Clinics; v. 70 n. 4 (2015); 247-249
Clinics; Vol. 70 Núm. 4 (2015); 247-249
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222761740664832